Skip to content

Electrolyte Disorders in Prediabetics and in Patients With Type 2 Diabetes Mellitus

Electrolyte Disorders in Prediabetics and in Patients With Type 2 Diabetes Mellitus

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05791188
Enrollment
200
Registered
2023-03-30
Start date
2023-05-31
Completion date
2024-06-30
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus and Electrolyte Disorders

Keywords

electrolytes diabetes mellitus

Brief summary

The aim of the study is to assess serum sodium \[Na+\], potassium \[K+\] magnesium \[Mg2+\], calcium \[Ca2+\], and chloride \[Cl-\] levels in patients who are prediabetic, diabetics and diabetic with complications (Diabetes mellitus type 2)

Detailed description

Diabetes mellitus is a chronic disease that imposes enormous socioeconomic burdens attributable to complications of various bodily systems. Diabetes affected 463 million people (9.3% of all people) in 2019 and will affect 700 million (10.9%) by 2045. According to the International Diabetes Federation (IDF), the prevalence of diabetes mellitus among Egyptian adults is 15.2%, which may be an underestimation. Therefore, diabetes mellitus should be thoroughly explored in terms of its risk factors, prevention, treatment, and consequences. Moreover, the general population should be aware of and well informed about all aspects of diabetes. Prediabetes is a precursor before the diagnosis of diabetes mellitus. Adults with prediabetes often may show no signs or symptoms of diabetes but will have blood glucose levels higher than normal. The normal blood glucose level is between 70 - 99 mg/dL. In patients with prediabetes, the blood glucose levels elevated between 110 - 125 mg/dL. Once the patient is diagnosed as prediabetes, he should be checked for progression to type 2 diabetes every one to two years. So early detection of prediabetes and so lifestyle changes through improved nutrition and physical activity are the first line treatment for preventing the transition from prediabetes to diabetes which can be as high as 70%. A normal HbA1C level is below 5.7%, a level of 5.7-6.4% indicates prediabetes, and a level of 6.5% or more indicates diabetes. Within the 5.7-6.4% prediabetes range, the higher HbA1C, the greater risk is for developing type 2 diabetes. Serum electrolytes are important cofactors for multiple enzymes and play a pivotal role in many key biological and physiological processes, including glucose metabolism. The excess or deficiency of these electrolytes was found to be linked to deleterious metabolism status. Diabetic patients frequently develop a constellation of electrolyte disorders. These disturbances are particularly common in decompensated diabetics, especially in the context of diabetic ketoacidosis or nonketotic hyperglycemic hyperosmolar syndrome.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* Patients with prediabetes who will be diagnosed by: * Glycated hemoglobin (HbA1C) test (6.1 - 6.4%) on two separate tests * Fasting blood sugar test 110-125 mg/dL (5.6 - 6.9 mmol/L) on two separate tests. * Glucose tolerance test 140 - 179 mg/dL (7.8 - 9.9 mmol/L) * Patients with Type 2 diabetes who will be diagnosed by: * Glycated hemoglobin (HbA1C) test ≥ 6.5% on two separate tests * Fasting blood sugar test ≥ 126 mg/dL (7 mmol/L) on two separate tests * Glucose tolerance test ≥ 200 mg/dL (11.1 mmol/L) * Random blood sugar test ≥ 200 mg/dL (11.1 mmol/L) * Patients with diabetic complications (nephropathy, neuropathy, cardiovascular, retinopathy, metabolic disorders, diabetic ketoacidosis)

Exclusion criteria

• Patients with Type 1 diabetes

Design outcomes

Primary

MeasureTime frameDescription
Serum sodiumbaselineassessment of serum sodium \[Na+\] in prediabetic and diabetic patients compared with controls
Serum potassiumbaselineassessment of serum potassium \[K+\] in prediabetic and diabetic patients compared with controls
Serum magnesiumbaselineassessment of serum magnesium \[Mg2+\] in prediabetic and diabetic patients compared with controls
Serum calciumbaselineassessment of serum calcium \[Ca2+\] in prediabetic and diabetic patients compared with controls
Serum chloridebaselineassessment of serum chloride \[Cl-\] in prediabetic and diabetic patients compared with controls

Contacts

Primary ContactAhmed Mostafa Saad, MBBChB
nammaali2015@aun.edu.eg01005852532
Backup ContactAlaa El-Din Abdel-Moniem El-Sayed, Professor
alaaeldeen.osman@med.au.edu.eg01112732730

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026